Skip to main content

Latest collections open to submissions

Developments in selective drug deliveries

Guest Edited by Koushik Debnath and
Vijayabhaskarreddy Junnuthula

Editor's choice

New Content ItemLow medication possession ratio and fewer prescribed benzodiazepine doses, was linked to an increased risk of overdose.

New Content Item

Lupeol suppressed inflammatory mediators in activated keratinocytes and alleviated atopic dermatitis-like skin inflammation in an animal model.


Aims and scope

BMC Pharmacology and Toxicology is an open access, peer-reviewed journal that considers articles on all aspects of chemically defined therapeutic and toxic agents. The journal welcomes submissions from all fields of experimental and clinical pharmacology including clinical trials and toxicology.

Featured news

Join our Editorial Board

We are recruiting new, international Editorial Board Members. If you are interested, please click the above link to submit your application.

Trending BMC Pharmacology and Toxicology articles

View the recent trending BMC Pharmacology and Toxicology articles

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Annual Journal Metrics

  • 2022 Citation Impact
    2.9 - 2-year Impact Factor
    2.9 - 5-year Impact Factor
    0.932 - SNIP (Source Normalized Impact per Paper)
    0.603 - SJR (SCImago Journal Rank)

    2023 Speed
    57 days submission to first editorial decision for all manuscripts (Median)
    178 days submission to accept (Median)

    2023 Usage
    400 Altmetric mentions

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal